Patient and Provider Safety is at the Core of Mass COVID-19 Immunization Effort
April 27th 2021As new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Read More
Oncology Pharmacists Play Essential Role in Oncology Care, Managing New Treatments
April 27th 2021Cynthia Lynch, MD, breast cancer program clinical advisor with Cancer Treatment Centers of America, said oncology pharmacists are vital team members who can help ensure optimal treatment and safety for patients with breast cancer.
Watch
More Than 100 Patient Groups Advocate for Affordable Prescription Drugs
April 27th 2021Patient and provider organizations urge the Department of Health and Human Services and the Biden administration to enact policies and protections that improve prescription drug affordability for people in the United States.
Read More
Study: More Belly Weight Increases Danger of Heart Disease Even If BMI Does Not Indicate Obesity
April 27th 2021A greater understanding of obesity and its impact on cardiovascular health highlights abdominal obesity, sometimes referred to as visceral adipose tissue (VAT), as a cardiovascular disease risk marker.
Read More
Study Identifies Genetic Mutations Linked to Peripartum Cardiomyopathy
April 27th 2021Researchers from the University of Pennsylvania School of Medicine have identified additional genetic mutations that strongly predispose otherwise healthy women to peripartum cardiomyopathy (PPCM), a rare condition characterized by weakness of the heart muscle that begins sometime during the final month of pregnancy through 5 months after delivery.
Read More
USP Outlines the COVID-19 Vaccine Handling Toolkit for World Immunization Week
April 26th 2021For World Immunization Week, Pharmacy Times® interviewed Nurisha Wade, MBA, VP of Global Healthcare Quality & Safety Center of Excellence at US Pharmacopeia (USP), and Farah Towfic, PharmD, MBA, director, CEO of Operations at USP, on USP’s COVID-19 Vaccine Handling Toolkit.
Watch
‘Pharmacy Is Literally Saving the World Through Immunizations,’ Says APhA CEO, EVP Scott Knoer
April 26th 2021Pharmacy Times® interviewed Scott J. Knoer, MS, PharmD, FASHP, the EVP and CEO of the American Pharmacists Association, on the Pharmacy and Medically Underserved Area Enhancement Act that was recently introduced in Congress.
Watch
COVID-19 Pandemic Causes Dramatic Shifts in Prescription Drug Spending
April 26th 2021The report further showed that drug expenditure in nonfederal hospitals declined 4.6%, while drug spending in home care settings increased 13%, and drug expenditures in nonfederal hospitals spiked in the 3 weeks immediately following the March 8, 2020 lockdown.
Read More
Study: Previous COVID-19 Infection Doesn’t Fully Protect Against Reinfection in Young People
April 26th 2021The study found that more than 10% of participants who were previously infected with SARS-CoV-2 (seropositive) became reinfected, compared with new infections in 50% of participants who had not been previously infected (seronegative).
Read More
The POETYK PSO-1 and POETYK PSO-2 trials, which evaluated deucravacitinib 6 mg once daily, met both co-primary endpoints versus placebo, with significantly more patients achieving Psoriasis Area and Severity Index (PASI) 75 response and a static Physician's Global Assessment score of clear or almost clear (sPGA 0/1) after 16 weeks of treatment with deucravacitinib.
Read More